The battle between infection and host immune responses of dengue virus and its implication in dengue disease pathogenesis

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Sun, Peifang ^a   Kochel, Tadeusz J ^b  

^a HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^b NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD123 ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD64 ANTIGEN; CXCL9 CHEMOKINE; FC RECEPTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12P70; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR ALPHA; VIRUS RECEPTOR;

ADAPTIVE IMMUNITY; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY DEPENDENT ENHANCEMENT; APOPTOSIS; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL MATURATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENGUE; DENGUE VIRUS 4; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; HOST; HOST CELL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MICROVASCULAR ENDOTHELIAL CELL; MIXED LYMPHOCYTE REACTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; REVIEW; RNA HYBRIDIZATION; VIREMIA; VIRUS LOAD; VIRUS MORPHOLOGY; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS VIRULENCE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTING CELL; CELL LINE; DENGUE VIRUS; GLYCOSYLATION; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; PATHOGENICITY; VIROLOGY;

ANTIGEN-ANTIBODY COMPLEX; ANTIGEN-PRESENTING CELLS; APOPTOSIS; CELL LINE; DENGUE; DENGUE VIRUS; GLYCOSYLATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; MACROPHAGE ACTIVATION; RECEPTORS, VIRUS; VIRUS REPLICATION;

EID: 84874905597     PISSN: 1537744X     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/843469     Document Type: Review

References (109)

1. Morrison A. C., Zielinski-Gutierrez E., Scott T. W., Rosenberg R., Defining challenges and proposing solutions for control of the virus vector Aedes aegypti. PLoS Medicine 2008 5 3, article e68 2-s2.0-41549115464 10.1371/journal.pmed.0050068 (Pubitemid 351471686)
2. Mathew A., Rothman A. L., Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunological Reviews 2008 225 1 300 313 2-s2.0-52049102222 10.1111/j.1600-065X.2008.00678.x
3. Halstead S. B., Pathogenisis of dengue: challenges to molecular biology. Science 1988 239 4839 476 481 2-s2.0-0023818748 (Pubitemid 18084309)
4. Gubler D. J., Surveillance for dengue and dengue hemorrhagic fever. Bulletin of the Pan American Health Organization 1989 23 4 397 404 2-s2.0-0024831670
5. Libraty D. H., Endy T. P., Houng H. S. H., Green S., Kalayanarooj S., Suntayakorn S., Chansiriwongs W., Vaughn D. W., Nisalak A., Ennis F. A., Rothman A. L., Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. Journal of Infectious Diseases 2002 185 9 1213 1221 2-s2.0-0036569001 10.1086/340365 (Pubitemid 34439127)
6. Vaughn D. W., Green S., Kalayanarooj S., Innis B. L., Nimmannitya S., Suntayakorn S., Endy T. P., Raengsakulrach B., Rothman A. L., Ennis F. A., Nisalak A., Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. Journal of Infectious Diseases 2000 181 1 2 9 2-s2.0-0033970916 10.1086/315215 (Pubitemid 30049026)
7. Srikiatkhachorn A., Plasma leakage in dengue haemorrhagic fever. Thrombosis and Haemostasis 2009 102 6 1042 1049 2-s2.0-72949104154 10.1160/TH09-03-0208
8. Srikiatkhachorn A., Krautrachue A., Ratanaprakarn W., Wongtapradit L., Nithipanya N., Kalayanarooj S., Nisalak A., Thomas S. J., Gibbons R. V., Mammen M. P. Jr., Libraty D. H., Ennis F. A., Rothman A. L., Green S., Natural history of plasma leakage in dengue hemorrhagic fever: a serial ultrasonographic study. Pediatric Infectious Disease Journal 2007 26 4 283 290 2-s2.0-34247169437 10.1097/01.inf.0000258612.26743.10 (Pubitemid 46596649)
9. Kalayanarooj S., Dengue classification: current WHO versus the newly suggested classification for better clinical application? Journal of the Medical Association of Thailand 94 supplement 3 74 84
10. Thomas L., Brouste Y., Najioullah F., Hochedez P., Hatchuel Y., Moravie V., Kaidomar S., King J. P., Besnier F., Abel S., Carmès S., Schmitt S., Brihier P., Meunier C., Cardoso T., Rosine J., Quenel P., Césaire R., Cabié A., Prospective and descriptive study of adult dengue cases in an emergency department, in Martinique. Medecine et Maladies Infectieuses 2010 40 8 480 489 2-s2.0-77956012571 10.1016/j.medmal.2009.10.001
11. Riaz M. M., Mumtaz K., Khan M. S., Patel J., Tariq M., Hilal H., Siddiqui S. A., Shezad F., Outbreak of dengue fever in Karachi 2006: a clinical perspective. Journal of the Pakistan Medical Association 2009 59 6 339 344 2-s2.0-66949173709
12. Shah G. S., Islam S., Das B. K., Clinical and laboratory profile of dengue infection in children. Kathmandu University Medical Journal 2006 4 13 40 43 2-s2.0-33748645567 (Pubitemid 44383799)
13. Noisakran S., Perng G. C., Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection. Experimental Biology and Medicine 2008 233 4 401 408 2-s2.0-41549147920 10.3181/0707-MR-198 (Pubitemid 351469295)
14. Nguyen T. H., Nguyen T. L., Lei H. Y., Lin Y. S., Le B. L., Huang K. J., Lin C. F., Do Q. H., Vu T. Q., Lam T. M., Yeh T. M., Huang J. H., Liu C. C., Halstead S. B., Association between sex, nutritional status, severity of dengue hemorrhagic fever, and immune status in infants with dengue hemorrhagic fever. American Journal of Tropical Medicine and Hygiene 2005 72 4 370 374 2-s2.0-18944395159 (Pubitemid 41278844)
15. Tee H. P., How S. H., Jamalludin A. R., Safhan M. N. F., Sapian M. M., Kuan Y. C., Sapari S., Risk factors associated with development of dengue haemorrhagic fever or dengue shock syndrome in adults in Hospital Tengku Ampuan Afzan Kuantan. Medical Journal of Malaysia 2009 64 4 316 320 2-s2.0-77958048605
16. Green S., Rothman A., Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Current Opinion in Infectious Diseases 2006 19 5 429 436 2-s2.0-33748366332 10.1097/01.qco.0000244047.31135.fa (Pubitemid 44338101)
17. Mondotte J. A., Lozach P. Y., Amara A., Gamarnik A. V., Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation. Journal of Virology 2007 81 13 7136 7148 2-s2.0-34250854515 10.1128/JVI.00116-07 (Pubitemid 46986649)
18. Pryor M. J., Gualano R. C., Lin B., Davidson A. D., Wright P. J., Growth restriction of dengue virus type 2 by site-specific mutagenesis of virus-encoded glycoproteins. Journal of General Virology 1998 79 11 2631 2639 2-s2.0-0031766084 (Pubitemid 28497615)
19. Pryor M. J., Wright P. J., Glycosylation mutants of dengue virus NS1 protein. Journal of General Virology 1994 75 5 1183 1187 2-s2.0-0028345969 (Pubitemid 24143165)
20. Somnuke P., Hauhart R. E., Atkinson J. P., Diamond M. S., Avirutnan P., N-linked glycosylation of dengue virus NS1 protein modulates secretion, cell-surface expression, hexamer stability, and interactions with human complement. Virology 2011 413 2 253 264 2-s2.0-79954633991 10.1016/j.virol.2011. 02.022
21. Bryant J. E., Calvert A. E., Mesesan K., Crabtree M. B., Volpe K. E., Silengo S., Kinney R. M., Huang C. Y. H., Miller B. R., Roehrig J. T., Glycosylation of the dengue 2 virus E protein at N67 is critical for virus growth in vitro but not for growth in intrathoracically inoculated Aedes aegypti mosquitoes. Virology 2007 366 2 415 423 2-s2.0-34548605884 10.1016/j.virol. 2007.05.007 (Pubitemid 47398913)
22. Sakoonwatanyoo P., Boonsanay V., Smith D. R., Growth and production of the dengue virus in C6/36 cells and identification of a laminin-binding protein as a candidate serotype 3 and 4 receptor protein. Intervirology 2006 49 3 161 172 2-s2.0-31144479643 10.1159/000089377 (Pubitemid 43131548)
23. Martínez-Barragán J. J., del Angel R. M., Identification of a putative coreceptor on Vero cells that participates in dengue 4 virus infection. Journal of Virology 2001 75 17 7818 7827 2-s2.0-0034879229 10.1128/JVI.75.17.7818-7827.2001 (Pubitemid 32743652)
24. Thepparit C., Smith D. R., Serotype-specific entry of dengue virus into liver cells: identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor. Journal of Virology 2004 78 22 12647 12656 2-s2.0-7644219512 10.1128/JVI.78.22.12647-12656.2004 (Pubitemid 39458782)
25. Jindadamrongwech S., Thepparit C., Smith D. R., Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. Archives of Virology 2004 149 5 915 927 2-s2.0-2442457815 10.1007/s00705-003- 0263-x (Pubitemid 38641472)
26. Reyes-Del Valle J., Chávez-Salinas S., Medina F., del Angel R. M., Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. Journal of Virology 2005 79 8 4557 4567 2-s2.0-16244364801 10.1128/JVI.79.8.4557-4567.2005 (Pubitemid 40464207)
27. Cabrera-Hernandez A., Thepparit C., Suksanpaisan L., Smith D. R., Dengue virus entry into liver (HepG2) cells is independent of hsp90 and hsp70. Journal of Medical Virology 2007 79 4 386 392 2-s2.0-33847654231 10.1002/jmv.20786 (Pubitemid 46355438)
28. Upanan S., Kuadkitkan A., Smith D. R., Identification of dengue virus binding proteins using affinity chromatography. Journal of Virological Methods 2008 151 2 325 328 2-s2.0-46949086037 10.1016/j.jviromet.2008.05.001
29. Chen Y., Maguire T., Hileman R. E., Fromm J. R., Esko J. D., Linhardt R. J., Marks R. M., Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nature Medicine 1997 3 8 866 871 2-s2.0-0030764559 10.1038/nm0897-866 (Pubitemid 27353446)
30. Miller J. L., deWet B. J. M., Martinez-Pomares L., Radcliffe C. M., Dwek R. A., Rudd P. M., Gordon S., The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathogens 2008 4 2, article e17 2-s2.0-40349100411 10.1371/journal.ppat.0040017 (Pubitemid 351340711)
31. Bielefeldt-Ohmann H., Meyer M., Fitzpatrick D. R., Mackenzie J. S., Dengue virus binding to human leukocyte cell lines: receptor usage differs between cell types and virus strains. Virus Research 2001 73 1 81 89 2-s2.0-0035055182 10.1016/S0168-1702(00)00233-1 (Pubitemid 32332986)
32. Chen S. T., Lin Y. L., Huang M. T., Wu M. F., Cheng S. C., Lei H. Y., Lee C. K., Chiou T. W., Wong C. H., Hsieh S. L., CLEC5A is critical for dengue-virus-induced lethal disease. Nature 2008 453 7195 672 676 2-s2.0-44449097101 10.1038/nature07013 (Pubitemid 351769308)
33. Watson A. A., O'callaghan C. A., Crystallization and X-ray diffraction analysis of human CLEC5A (MDL-1), a dengue virus receptor. Acta Crystallographica F 2009 66 1 29 31 2-s2.0-75149159139 10.1107/S1744309109047915
34. Tassaneetrithep B., Burgess T. H., Granelli-Piperno A., Trumpfheller C., Finke J., Sun W., Eller M. A., Pattanapanyasat K., Sarasombath S., Birx D. L., Steinman R. M., Schlesinger S., Marovich M. A., DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. Journal of Experimental Medicine 2003 197 7 823 829 2-s2.0-0344642934 10.1084/jem.20021840 (Pubitemid 36437860)
35. Marovich M., Grouard-Vogel G., Louder M., Eller M., Sun W., Wu S. J., Putvatana R., Murphy G., Tassaneetrithep B., Burgess T., Birx D., Hayes C., Schlesinger-Frankel S., Mascola J., Human dendritic cells as targets of dengue virus infection. Journal of Investigative Dermatology Symposium Proceedings 2001 6 3 219 224 (Pubitemid 33758578)
36. Lozach P. Y., Burleigh L., Staropoli I., Navarro-Sanchez E., Harriague J., Virelizier J. L., Rey F. A., Desprès P., Arenzana-Seisdedos F., Amara A., Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals. The Journal of Biological Chemistry 2005 280 25 23698 23708 2-s2.0-21244462832 10.1074/jbc.M504337200 (Pubitemid 40884852)
37. Salas-Benito J. S., del Angel R. M., Identification of two surface proteins from C6/36 cells that bind dengue type 4 virus. Journal of Virology 1997 71 10 7246 7252 2-s2.0-0030768318 (Pubitemid 27391659)
38. Salas-Benito J., Valle J. R. D., Salas-Benito M., Ceballos-Olvera I., Mosso C., del Angel R. M., Evidence that the 45-kD glycoprotein, part of a putative dengue virus receptor complex in the mosquito cell line C6/36, is a heat-shock-related protein. American Journal of Tropical Medicine and Hygiene 2007 77 2 283 290 2-s2.0-34848906249 (Pubitemid 351859277)
39. Germi R., Crance J. M., Garin D., Guimet J., Lortat-Jacob H., Ruigrok R. W. H., Zarski J. P., Drouet E., Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus. Virology 2002 292 1 162 168 2-s2.0-0036056151 10.1006/viro.2001.1232
40. Dalrymple N., Mackow E. R., Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors. Journal of Virology 2011 85 18 9478 9485 10.1128/JVI.05008-11
41. Kangwanpong D., Bhamarapravati N., Lucia H. L., Diagnosing dengue virus infection in archived autopsy tissues by means of the in situ PCR method: a case report. Clinical and Diagnostic Virology 1995 3 2 165 172 2-s2.0-0028796646 10.1016/0928-0197(94)00032-P
42. de Araújo J. M. G., Schatzmayr H. G., de Filippis A. M. B., dos Santos F. B., Cardoso M. A., Britto C., Coelho J. M. C. O., Nogueira R. M. R., A retrospective survey of dengue virus infection in fatal cases from an epidemic in Brazil. Journal of Virological Methods 2009 155 1 34 38 2-s2.0-57549118906 10.1016/j.jviromet.2008.09.023
43. Durbin A. P., Vargas M. J., Wanionek K., Hammond S. N., Gordon A., Rocha C., Balmaseda A., Harris E., Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology 2008 376 2 429 435 2-s2.0-44649085672 10.1016/j.virol.2008.03.028
44. Mota J., Rico-Hesse R., Dengue virus tropism in humanized mice recapitulates human dengue fever. PLoS ONE 2011 6 6 2-s2.0-79958704176 10.1371/journal.pone.0020762 e20762
45. Añez G., Men R., Eckels K. H., Lai C. J., Passage of dengue virus type 4 vaccine candidates in fetal rhesus lung cells selects heparin-sensitive variants that result in loss of infectivity and immunogenicity in rhesus macaques. Journal of Virology 2009 83 20 10384 10394 2-s2.0-70349756956 10.1128/JVI.01083-09
46. Shresta S., Sharar K. L., Prigozhin D. M., Beatty P. R., Harris E., Murine model for dengue virus-induced lethal disease with increased vascular permeability. Journal of Virology 2006 80 20 10208 10217 2-s2.0-33749467342 10.1128/JVI.00062-06 (Pubitemid 44522614)
47. Prestwood T. R., Prigozhin D. M., Sharar K. L., Zellweger R. M., Shresta S., A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads. Journal of Virology 2008 82 17 8411 8421 2-s2.0-50149086295 10.1128/JVI.00611-08
48. Ryan E. J., Dring M., Ryan C. M., McNulty C., Stevenson N. J., Lawless M. W., Crowe J., Nolan N., Hegarty J. E., O'Farrelly C., Variant in CD209 promoter is associated with severity of liver disease in chronic hepatitis C virus infection. Human Immunology 2010 71 8 829 832 10.1016/j.humimm.2010.05.007
49. Wang L., Chen R. F., Liu J. W., Lee I. K., Lee C. P., Kuo H. C., Huang S. K., Yang K. D., DC-SIGN (CD209) promoter -336 A/G polymorphism is associated with dengue hemorrhagic fever and correlated to DC-SIGN expression and immune augmentation. PLoS Neglected Tropical Diseases 2011 5 1, article e934 2-s2.0-79851480892 10.1371/journal.pntd.0000934
50. Russell P. K., Udomsakdi S., Halstead S. B., Antibody response in dengue and dengue hemorrhagic fever. Japanese Journal of Medical Science and Biology 1967 20 103 108 2-s2.0-0014190308
51. Guzmán M. G., Kourí G., Valdés L., Bravo J., Vázquez S., Halstead S. B., Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. Revista Panamericana de Salud Publica 2002 11 4 223 227 2-s2.0-0036107484 (Pubitemid 34555771)
52. Kliks S. C., Nimmanitya S., Nisalak A., Burke D. S., Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. American Journal of Tropical Medicine and Hygiene 1988 38 2 411 419 2-s2.0-0023864994 (Pubitemid 18086128)
53. Sun P., Bauza K., Pal S., Liang Z., Wu S. J., Beckett C., Burgess T., Porter K., Infection and activation of human peripheral blood monocytes by dengue viruses through the mechanism of antibody-dependent enhancement. Virology 421 2 245 252 10.1016/j.virol.2011.08.026
54. Laoprasopwattana K., Libraty D. H., Endy T. P., Nisalak A., Chunsuttiwat S., Vaughn D. W., Reed G., Ennis F. A., Rothman A. L., Green S., Dengue virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection. Journal of Infectious Diseases 2005 192 3 510 519 2-s2.0-22544457161 10.1086/431520 (Pubitemid 41023132)
55. Stokes A., Wardley R. C., ADCC and complement-dependent lysis as immune mechanisms against EHV-1 infection in the horse. Research in Veterinary Science 1988 44 3 295 302 2-s2.0-0024004847
56. Fust G., The biological role of the complement system and the clinical importance of complement measurements. Haematologia 1978 12 1-4 85 106 2-s2.0-0018045534 (Pubitemid 10103693)
57. Iannello A., Debbeche O., Samarani S., Ahmad A., Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS. Journal of Leukocyte Biology 2008 84 1 1 26 2-s2.0-46949088469 10.1189/jlb.0907650 (Pubitemid 351960277)
58. Stoiber H., Soederholm A., Wilflingseder D., Gusenbauer S., Hildgartner A., Dierich M. P., Complement and antibodies: a dangerous liaison in HIV infection? Vaccine 2008 26 8 I79 I85 2-s2.0-57649237596 10.1016/j.vaccine.2008. 11.050
59. Anolik J. H., B cell biology and dysfunction in SLE. Bulletin of the NYU Hospital for Joint Diseases 2007 65 3 182 186 2-s2.0-38449101693 (Pubitemid 351412130)
60. Laoprasopwattana K., Libraty D. H., Endy T. P., Nisalak A., Chunsuttiwat S., Ennis F. A., Rothman A. L., Green S., Antibody-dependent cellular cytotoxicity mediated by plasma obtained before secondary dengue virus infections: potential involvement in early control of viral replication. Journal of Infectious Diseases 2007 195 8 1108 1116 2-s2.0-34047221846 10.1086/512860 (Pubitemid 46543441)
61. Yamanaka A., Kosugi S., Konishi E., Infection-enhancing and -neutralizing activities of mouse monoclonal antibodies against dengue type 2 and 4 viruses are controlled by complement levels. Journal of Virology 2008 82 2 927 937 2-s2.0-37849009012 10.1128/JVI.00992-07
62. Mehlhop E., Ansarah-Sobrinho C., Johnson S., Engle M., Fremont D. H., Pierson T., Diamond M. S., Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner. Cell Host and Microbe 2007 2 6 417 426 2-s2.0-36749028784 10.1016/j.chom.2007.09.015 (Pubitemid 350215325)
63. Malasit P., Complement and dengue haemorrhagic fever/shock syndrome. The Southeast Asian Journal of Tropical Medicine and Public Health 1987 18 3 316 320 2-s2.0-0023409793
64. Thein S., Aaskov J., Myint T., Shwe T. N., Saw T. T., Zaw A., Changes in levels of anti-dengue virus IgG subclasses in patients with disease of varying severity. Journal of Medical Virology 1993 40 2 102 106 2-s2.0-0027159687 (Pubitemid 23169736)
65. Koraka P., Suharti C., Setiati T. E., Mairuhu A. T. A., van Gorp E., Hach C. E., Juffrie M., Sutaryo J., van der Meer G. M., Groen J., Osterhaus A. D. M. E., Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection. Journal of Clinical Microbiology 2001 39 12 4332 4338 2-s2.0-0035209360 10.1128/JCM.39.12.4332-4338. 2001 (Pubitemid 33117119)
66. Loke H., Bethell D., Phuong C. X. T., Day N., White N., Farrar J., Hill A., Susceptibility to dengue hemorrhagic fever in Vietnam: evidence of an association with variation in the vitamin D receptor and FC γ receptor IIA genes. American Journal of Tropical Medicine and Hygiene 2002 67 1 102 106 2-s2.0-0036656348 (Pubitemid 35034327)
67. Goncalvez A. P., Engle R. E., Claire M. S., Purcell R. H., Lai C. J., Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proceedings of the National Academy of Sciences of the United States of America 2007 104 22 9422 9427 2-s2.0-34547141259 10.1073/pnas.0703498104 (Pubitemid 47185795)
68. Azeredo E. L., Neves-Souza P. C., Alvarenga A. R., Reis S. R. N. I., Torrentes-Carvalho A., Zagne S. M. O., Nogueira R. M. R., Oliveira-Pinto L. M., Kubelka C. F., Differential regulation of toll-like receptor-2, toll-like receptor-4, CD16 and human leucocyte antigen-DR on peripheral blood monocytes during mild and severe dengue fever. Immunology 2010 130 2 202 216 2-s2.0-77952057526 10.1111/j.1365-2567.2009.03224.x
69. Ziegler-Heitbrock L., The CD14+ CD16+ blood monocytes: their role in infection and inflammation. Journal of Leukocyte Biology 2007 81 3 584 592 2-s2.0-33847789122 10.1189/jlb.0806510 (Pubitemid 46393535)
70. Sun P., Fernandez S., Marovich M. A., Palmer D. R., Celluzzi C. M., Boonnak K., Liang Z., Subramanian H., Porter K. R., Sun W., Burgess T. H., Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus. Virology 2009 383 2 207 215 2-s2.0-58149116611 10.1016/j.virol.2008.10.022
71. Ho L. J., Wang J. J., Shaio M. F., Kao C. L., Chang D. M., Han S. W., Lai J. H., Infection of human dendritic cells by Dengue virus causes cell maturation and cytokine production. Journal of Immunology 2001 166 3 1499 1506 2-s2.0-0035253347
72. Libraty D. H., Pichyangkul S., Ajariyakhajorn C., Endy T. P., Ennis F. A., Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. Journal of Virology 2001 75 8 3501 3508 2-s2.0-0035078793 10.1128/JVI.75.8.3501-3508.2001 (Pubitemid 32246359)
73. Limon-Flores A. Y., Perez-Tapia M., Estrada-Garcia I., Vaughan G., Escobar-Gutierrez A., Calderon-Amador J., Herrera-Rodriguez S. E., Brizuela-Garcia A., Heras-Chavarria M., Flores-Langarica A., Barron L. C., Flores-Romo L., Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells. International Journal of Experimental Pathology 2005 86 5 323 334 2-s2.0-26244434330 10.1111/j.0959-9673.2005.00445.x (Pubitemid 41413627)
74. Kwan W. H., Helt A. M., Marañón C., Barbaroux J. B., Hosmalin A., Harris E., Fridman W. H., Mueller C. G. F., Dendritic cell precursors are permissive to dengue virus and human immunodeficiency virus infection. Journal of Virology 2005 79 12 7291 7299 2-s2.0-19944418829 10.1128/JVI.79.12.7291-7299.2005 (Pubitemid 40756764)
75. Sun P., Celluzzi C. M., Marovich M., Subramanian H., Eller M., Widjaja S., Palmer D., Porter K., Sun W., Burgess T., CD40 ligand enhances dengue viral infection of dendritic cells: a possible mechanism for T cell-mediated immunopathology. Journal of Immunology 2006 177 9 6497 6503 2-s2.0-33750301229 (Pubitemid 44628869)
76. Nightingale Z. D., Patkar C., Rothman A. L., Viral replication and paracrine effects result in distinct, functional responses of dendritic cells following infection with dengue 2 virus. Journal of Leukocyte Biology 2008 84 4 1028 1038 2-s2.0-54249144531 10.1189/jlb.0208105
77. Pichyangkul S., Endy T. P., Kalayanarooj S., Nisalak A., Yongvanitchit K., Green S., Rothman A. L., Ennis F. A., Libraty D. H., A blunted blood plasmacytoid dendritic cell response to an acute systemic viral infection is associated with increased disease severity. Journal of Immunology 2003 171 10 5571 5578 2-s2.0-0242410830 (Pubitemid 37432848)
78. Carr J. M., Hocking H., Bunting K., Wright P. J., Davidson A., Gamble J., Burrell C. J., Li P., Supernatants from dengue virus type-2 infected macrophages induce permeability changes in endothelial cell monolayers. Journal of Medical Virology 2003 69 4 521 528 2-s2.0-0037400099 10.1002/jmv.10340 (Pubitemid 36249866)
79. Tsai Y. T., Chang S. Y., Lee C. N., Kao C. L., Human TLR3 recognizes dengue virus and modulates viral replication in vitro. Cellular Microbiology 2009 11 4 604 615 2-s2.0-62149139785 10.1111/j.1462-5822.2008.01277.x
80. Tuiskunen A., Monteil V., Plumet S., Wahlström M., Duong V., Buchy P., Lundkvist A., Tolou H., Leparc-Goffart I., Phenotypic and genotypic characterization of dengue virus isolates differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndrome. Archives of Virology 2011 156 11 2023 2032 10.1007/s00705-011-1100-2
81. Silveira G. F., Meyer F., Delfraro A., Mosimann A. L. P., Coluchi N., Vasquez C., Probst C. M., Báfica A., Bordignon J., dos Santos C. N. D., Dengue virus type 3 isolated from a fatal case with visceral complications induces enhanced proinflammatory responses and apoptosis of human dendritic cells. Journal of Virology 2011 85 11 5374 5383 2-s2.0-79956093737 10.1128/JVI.01915-10
82. Palmer D. R., Sun P., Celluzzi C., Bisbing J., Pang S., Sun W., Marovich M. A., Burgess T., Differential effects of dengue virus on infected and bystander dendritic cells. Journal of Virology 2005 79 4 2432 2439 2-s2.0-13444304281 10.1128/JVI.79.4.2432-2439.2005 (Pubitemid 40204598)
83. Mosquera J. A., Hernandez J. P., Valero N., Espina L. M., Añez G. J., Ultrastructural studies on dengue virus type 2 infection of cultured human monocytes. Virology Journal 2005 2, article 26 2-s2.0-19344378215 10.1186/1743-422X-2-26 (Pubitemid 40721063)
84. Limonta D., Capó V., Torres G., Pérez A. B., Guzmán M. G., Apoptosis in tissues from fatal dengue shock syndrome. Journal of Clinical Virology 2007 40 1 50 54 2-s2.0-34548126493 10.1016/j.jcv.2007.04.024 (Pubitemid 47302858)
85. Courageot M. P., Catteau A., Desprès P., Mechanisms of Dengue virus-induced cell death. Advances in Virus Research 2003 60 157 186 2-s2.0-0642379630 10.1016/S0065-3527(03)60005-9 (Pubitemid 137639376)
86. Umareddy I., Pluquet O., Wang Q. Y., Vasudevan S. G., Chevet E., Gu F., Dengue virus serotype infection specifies the activation of the unfolded protein response. Virology Journal 2007 4, article 91 2-s2.0-35748966391 10.1186/1743-422X-4-91 (Pubitemid 350044016)
87. Matsuda T., Almasan A., Tomita M., Tamaki K., Saito M., Tadano M., Yagita H., Ohta T., Mori N., Dengue virus-induced apoptosis in hepatic cells is partly mediated by Apo2 ligand/tumour necrosis factor-related apoptosis-inducing ligand. Journal of General Virology 2005 86 4 1055 1065 (Pubitemid 40485663)
88. Liao H., Xu J., Huang J., FasL/Fas pathway is involved in dengue virus induced apoptosis of the vascular endothelial cells. Journal of Medical Virology 2010 82 8 1392 1399 2-s2.0-77956597794 10.1002/jmv.21815
89. Morchang A., Yasamut U., Netsawang J., Noisakran S., Wongwiwat W., Songprakhon P., Srisawat C., Puttikhunt C., Kasinrerk W., Malasit P., Yenchitsomanus P. T., Limjindaporn T., Cell death gene expression profile: role of RIPK2 in dengue virus-mediated apoptosis. Virus Research 2011 156 1-2 25 34 2-s2.0-79951814526 10.1016/j.virusres.2010.12.012
90. Nagila A., Netsawang J., Srisawat C., Noisakran S., Morchang A., Yasamut U., Puttikhunt C., Kasinrerk W., Malasit P., Yenchitsomanus P. T., Limjindaporn T., Role of CD137 signaling in dengue virus-mediated apoptosis. Biochemical and Biophysical Research Communications 2011 410 3 428 433 10.1016/j.bbrc.2011.05. 151
91. Ochoa M. V., Cordero J. G., Castañeda B. G., Argumedo L. S., Sepúlveda N. V., Barrón L. C., A clinical isolate of dengue virus and its proteins induce apoptosis in HMEC-1 cells: a possible implication in pathogenesis. Archives of Virology 2009 154 6 919 928 2-s2.0-67349167968 10.1007/s00705-009-0396-7
92. Shafee N., AbuBakar S., Dengue virus type 2 NS3 protease and NS2B-NS3 protease precursor induce apoptosis. Journal of General Virology 2003 84 8 2191 2195 2-s2.0-0042167388 10.1099/vir.0.19022-0 (Pubitemid 36927250)
93. + T-cell responses to different HIV proteins have discordant associations with viral load. Nature Medicine 2007 13 1 46 53 2-s2.0-33846101731 10.1038/nm1520 (Pubitemid 46067385)
94. Yi J. S., Cox M. A., Zajac A. J., T-cell exhaustion: characteristics, causes and conversion. Immunology 2010 129 4 474 481 2-s2.0-77949357362 10.1111/j.1365-2567.2010.03255.x
95. Cox M. A., Zajac A. J., Shaping successful and unsuccessful CD8 T cell responses following infection. Journal of Biomedicine and Biotechnology 2010 2010 12 2-s2.0-77951684508 10.1155/2010/159152 159152
96. Dejnirattisai W., Duangchinda T., Lin C. L. S., Vasanawathana S., Jones M., Jacobs M., Malasit P., Xu X. N., Screaton G., Mongkolsapaya J., A complex interplay among virus, dendritic cells, T cells, and cytokines in dengue virus infections. Journal of Immunology 2008 181 9 5865 5874 2-s2.0-58749105842
97. + T cell polarization by dengue virus-infected dendritic cells. Journal of Infectious Diseases 2011 203 12 1763 1774 2-s2.0-79957483245 10.1093/infdis/jir197
98. Mongkolsapaya J., Dejnirattisai W., Xu X. N., Vasanawathana S., Tangthawornchaikul N., Chairunsri A., Sawasdivorn S., Duangchinda T., Dong T., Rowland-Jones S., Yenchitsomanus P. T., McMichael A., Malasit P., Screaton G., Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nature Medicine 2003 9 7 921 927 2-s2.0-0038379214 10.1038/nm887 (Pubitemid 36889936)
99. Green S., Pichyangkul S., Vaughn D. W., Kalayanarooj S., Nimmannitya S., Nisalak A., Kurane I., Rothman A. L., Ennis F. A., Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. Journal of Infectious Diseases 1999 180 5 1429 1435 2-s2.0-0032754317 10.1086/315072 (Pubitemid 29506442)
100. Mathew A., Kurane I., Green S., Vaughn D. W., Kalayanarooj S., Suntayakorn S., Ennis F. A., Rothman A. L., Impaired T cell proliferation in acute dengue infection. Journal of Immunology 1999 162 9 5609 5615 2-s2.0-0033136708 (Pubitemid 29307175)
101. Myint K. S., Endy T. P., Mongkolsirichaikul D., Manomuth C., Kalayanarooj S., Vaughn D. W., Nisalak A., Green S., Rothman A. L., Ennis F. A., Libraty D. H., Cellular immune activation in children with acute dengue virus infections is modulated by apoptosis. Journal of Infectious Diseases 2006 194 5 600 607 2-s2.0-33748037380 10.1086/506451 (Pubitemid 44297845)
102. Duangchinda T., Dejnirattisai W., Vasanawathana S., Limpitikul W., Tangthawornchaikul N., Malasit P., Mongkolsapaya J., Screaton G., Immunodominant T-cell responses to dengue virus NS3 are associated with DHF. Proceedings of the National Academy of Sciences of the United States of America 2010 107 39 16922 16927 10.1073/pnas.1010867107
103. Appanna R., Tan L. H., See L. L. C., Phoay L. T., Vadivelu J., Devi S., Cross-reactive T-cell responses to the nonstructural regions of dengue viruses among dengue fever and dengue hemorrhagic fever patients in Malaysia. Clinical and Vaccine Immunology 2007 14 8 969 977 2-s2.0-35248814431 10.1128/CVI.00069-07
104. Zivna I., Green S., Vaughn D. W., Kalayanarooj S., Stephens H. A. F., Chandanayingyong D., Nisalak A., Ennis F. A., Rothman A. L., T cell responses to an HLA-B07-restricted epitope on the dengue NS3 protein correlate with disease severity. Journal of Immunology 2002 168 11 5959 5965 2-s2.0-0036604103 (Pubitemid 34556187)
105. + T-cells with disease severity in adults with Dengue. Immune Network 10 5 164 172 10.4110/in.2010.10.5.164
106. Lai C. Y., Tsai W. Y., Lin S. R., Kao C. L., Hu H. P., King C. C., Wu H. C., Chang G. J., Wang W. K., Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. Journal of Virology 2008 82 13 6631 6643 2-s2.0-45749131789 10.1128/JVI.00316-08 (Pubitemid 351875140)
107. Simmons C. P., Dong T., Chau N. V., Dung N. T. P., Chau T. N. B., Thao L. T. T., Dung N. T., Hien T. T., Rowland-Jones S., Farrar J., Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections. Journal of Virology 2005 79 9 5665 5675 2-s2.0-20244381983 10.1128/JVI.79.9.5665-5675.2005 (Pubitemid 40548235)
108. Mangada M. M., Endy T. P., Nisalak A., Chunsuttiwat S., Vaughn D. W., Libraty D. H., Green S., Ennis F. A., Rothman A. L., Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren. Journal of Infectious Diseases 2002 185 12 1697 1703 2-s2.0-0037097789 10.1086/340822 (Pubitemid 34615461)
109. Hatch S., Endy T. P., Thomas S., Mathew A., Potts J., Pazoles P., Libraty D. H., Gibbons R., Rothman A. L., Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection. Journal of Infectious Diseases 2011 203 9 1282 1291 2-s2.0-79954588278 10.1093/infdis/jir012